REDHILL BIOPHARMA LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - ILa | -.--% |
|
-9.57% | -17.72% |
| 05-06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
| 05-06 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 90.85B | ||||||
| 39.02B | ||||||
| 33.46B | ||||||
| 14.51B | ||||||
| 13.22B |
